CAFC denies J&J's Zytiga patent protection appeal

The U.S. Court of Appeals on Nov. 21 denied a request for a temporary injunction against generic versions of Zytiga abiraterone acetate, filed by Johnson & Johnson (NYSE:JNJ) after a district court invalidated its patent claims in October (see “J&J Appeals District Court Decision Invalidating Zytiga Patent”)...